DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Celgene (NASDAQ: CELG)

119.52 1.30 (1.10%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $119.52 1.10%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $118.56
Previous Close $118.22
Daily Range $118.52 - $119.89
52-Week Range $82.90 - $129.06
Market Cap $94.8B
P/E Ratio 40.93
Dividend (Yield) $0.00 (0.0%)
Volume 4,288,088
Average Daily Volume 4,002,872
Current FY EPS $4.07

Sector

Healthcare

Industry

Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary Rss Feed

3 Biotech Stocks That Could Grow Faster than Apple

Apple is the king to which all other stocks are compared. However, these three biotech stocks could be poised to trump the tech giant's phenomenal growth rate.

Sector's Smaller Players Show The Way

A $1 Billion Bet on Cancer Cures

Celgene hands $1 Billion to Juno Therapeutics and health insurance on the exchanges will climb 4.4% next year.

Blame the E.U.; Don't Ignore the Good News; ... But Stay Skeptical: Jim Cramer's Best Blogs

Multiple Observations On Celgene's Latest Licensing Deals, And Its Valuation

Seeking Alpha's Biotech Weekly: Celgene-Juno, Gilead's HIV NDA, Happy 4th!

Celgene Goes For Broke

The Zacks Analyst Blog Highlights: Celgene, Juno Therapeutics, Intercept, BioMarin and Sarepta - Pre

The Zacks Analyst Blog Highlights: Celgene, Juno Therapeutics, Intercept, BioMarin and Sarepta - Press Releases

3 Health Care Stocks On The Rise

Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point

See More CELG News...

CELG's Top Competitors

CELG $119.52 (1.10%)
Current stock: CELG
AMGN $153.26 (-1.12%)
Current stock: AMGN
GILD $115.04 (-0.84%)
Current stock: GILD
$0.00 (0.00%)
Current stock: